A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.
Experimental Drug Acquiring Popularity Via Social Media
Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to message these profiles directly for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and assertions of next-day British shipping. Vendors promote the substance there before directing buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Professionals Voice Concerns
However, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the UK is worrisome and could result in individuals administering products of unknown origin.
Some professionals stated the demand for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.
Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and customer regulations, risking fines, prosecution or imprisonment.
Service Reaction and Content Removal
According to TikTok, the service has removed violative content and banned related keywords and search suggestions. The organization stated it was committed to keeping the service safe and investing in enhancing compliance measures.
Digital Trading Activities
Investigations also discovered communities with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, glowing testimonials and detailed instructions for preparing or administering at residence.
After minutes of joining one group, a seller posted contact information, where most purchases occur. The vendor sent an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about weight, medical conditions or previous experience.
Product Details and Costs
Inside these groups, messages show dark colored packages with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for Telegram stated it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering substances they cannot confirm. Even if the research behind retatrutide is valid, these digital versions may not include what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of an online medical service linked the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has already encountered individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may subject users to potentially significant medical dangers”.
